NCT06264440View on ClinicalTrials.gov

A Study to Assess the Potential for Gastric-pH Dependent Drug-Drug Interactions of BIIB122 With a Proton Pump Inhibitor in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 12, 2024

Primary Completion Date

June 18, 2024

Study Completion Date

June 18, 2024

Conditions
Healthy Volunteer
Interventions
DRUG

BIIB122

Administered as specified in the treatment arm.

DRUG

Rabeprazole

Administered as specified in the treatment arm.

Trial Locations (1)

78744

PPD Development, LP, Austin

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT06264440 - A Study to Assess the Potential for Gastric-pH Dependent Drug-Drug Interactions of BIIB122 With a Proton Pump Inhibitor in Healthy Participants | Biotech Hunter | Biotech Hunter